Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Enterprise Products Stock Undervalued: Is it a Strong Entry Point?
Enterprise Products Stock Undervalued: Is it a Strong Entry Point?

Enterprise Products Partners LP EPD is trading at a trailing 12-month EV/EBITDA multiple of 11.61x, which is lower than the broader industry average of 11.90x. Enbridge Inc. ENB and Kinder Morgan

What Makes Rapid Micro Biosystems (RPID) a New Buy Stock
What Makes Rapid Micro Biosystems (RPID) a New Buy Stock

Investors might want to bet on Rapid Micro Biosystems, Inc. (RPID), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates

What Makes uCloudlink Group (UCL) a New Buy Stock
What Makes uCloudlink Group (UCL) a New Buy Stock

uCloudlink Group Inc. Sponsored ADR (UCL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings

New Jersey Resources (NJR) Upgraded to Buy: Here's Why
New Jersey Resources (NJR) Upgraded to Buy: Here's Why

New Jersey Resources (NJR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which

VAREX IMAGING (VREX) Upgraded to Strong Buy: Here's Why
VAREX IMAGING (VREX) Upgraded to Strong Buy: Here's Why

VAREX IMAGING (VREX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates

Skillsoft (SKIL) Upgraded to Buy: Here's Why
Skillsoft (SKIL) Upgraded to Buy: Here's Why

Skillsoft Corp. (SKIL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates --

All You Need to Know About Gerdau (GGB) Rating Upgrade to Buy
All You Need to Know About Gerdau (GGB) Rating Upgrade to Buy

Gerdau (GGB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most

Kolibri Global Energy Inc. (KGEI) Upgraded to Buy: Here's What You Should Know
Kolibri Global Energy Inc. (KGEI) Upgraded to Buy: Here's What You Should Know

Kolibri Global Energy Inc. (KGEI) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates

Kyntra Bio (KYNB) Upgraded to Buy: Here's What You Should Know
Kyntra Bio (KYNB) Upgraded to Buy: Here's What You Should Know

Kyntra Bio (KYNB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the

EXC vs. FE: Which Utility Stock Offers Stronger Potential in 2026?
EXC vs. FE: Which Utility Stock Offers Stronger Potential in 2026?

The Zacks Utility - Electric Power industry, supported by its regulated structure offer, stable returns and long-term earnings. Utilities operate under a regulated framework, enabling companies to

Is MasterCard (MA) a Solid Growth Stock? 3 Reasons to Think "Yes"
Is MasterCard (MA) a Solid Growth Stock? 3 Reasons to Think "Yes"

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Analog Devices (ADI) is an Incredible Growth Stock: 3 Reasons Why
Analog Devices (ADI) is an Incredible Growth Stock: 3 Reasons Why

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't

UBER Stock Plunges 23.4% in 6 Months:Time to Hold or Fold?
UBER Stock Plunges 23.4% in 6 Months:Time to Hold or Fold?

Shares of Uber Technologies UBER) have declined 23.4% over the past six months against the Zacks  Internet-Services industry’s growth of 20.7%. However, it outperformed fellow industry players, Lyft

KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug
KYMR Stock Up as FDA Grants Fast Track Designation to Asthma Drug

Kymera Therapeutics KYMR announced that the FDA has granted a Fast Track designation to its lead candidate, KT-621, for the treatment of moderate-to-severe eosinophilic asthma. KYMR shares rose 4%

NU Appears Expensive to Its Industry: Is the Premium Warranted?
NU Appears Expensive to Its Industry: Is the Premium Warranted?

Nu Holdings Ltd. NU is currently trading at a 16.1X forward 12-month price-to-earnings, substantially higher than the industry’s 10.91X. While the stock appears expensive, the forward-looking

Momentum ETF (SPMO) Hits New 52-Week High
Momentum ETF (SPMO) Hits New 52-Week High

Invesco S&P 500 Momentum ETF SPMO is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 46.84% from its 52-week low price of $84.86 per share.

Surging Earnings Estimates Signal Upside for Peloton (PTON) Stock
Surging Earnings Estimates Signal Upside for Peloton (PTON) Stock

Peloton (PTON) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its

Earnings Estimates Rising for Murphy Oil (MUR): Will It Gain?
Earnings Estimates Rising for Murphy Oil (MUR): Will It Gain?

Murphy Oil (MUR) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with

MRK, Daiichi's BLA for ADC Drug Gets FDA Priority Tag in Lung Cancer
MRK, Daiichi's BLA for ADC Drug Gets FDA Priority Tag in Lung Cancer

Merck MRK and its Japanese partner Daiichi Sankyo announced that the FDA has accepted the biologics license application (BLA) seeking approval for ifinatamab deruxtecan (I-DXd), a B7-H3-directed DXd

HSBC Launches TDS in U.S., Boosts Digital Payments & Global Liquidity
HSBC Launches TDS in U.S., Boosts Digital Payments & Global Liquidity

HSBC Holdings plc HSBC has introduced its Tokenized Deposit Service (TDS) in the United States to enable faster and smoother money transfers using blockchain technology. The move represents the